Table 1.
Week 0 | Week 4 | Week 8 | Week 12 | |
---|---|---|---|---|
Staff Measures | ||||
Demographic Questionnaire | X | |||
Tobacco/Cannabis Use History | X | |||
Timeline Follow-Back (TLFB)-- Weekly | X | X | X | X |
Adverse Events—Weekly | X | X | X | |
Medication List—Weekly | X | X | X | |
Medical History | ||||
Medical and psychiatric history | X | |||
Medication List | X | |||
Clinical Assessment | ||||
M.I.N.I. Neuropsychiatric Interview | X | |||
Clinician Administered Cognitive Testing | ||||
Hopkins Verbal Learning Test | X | X | X | X |
Oral Trail Making Test | X | X | X | X |
Paced Auditory Serial Addition Test | X | X | X | X |
Labs | ||||
Urine pregnancy tests (people of childbearing potential, ages 18–55) | X | X | X | |
Urine Drug Screen | X | X | X | X |
Salivary Cotinine** | X | X | ||
Self-Report Participant Measures | ||||
Tobacco-Related Measures | ||||
Contemplation Ladder—Tobacco Smoking* | X | X | X | X |
Questionnaire of Smoking Urges Fagerstrom Test of Nicotine Dependence | X | X | X | X |
Fagerstrom Test of Nicotine Dependence | X | X | X | X |
Minnesota Tobacco Withdrawal Scale | X | X | X | X |
Cannabis-Related Measures | ||||
Contemplation Ladder—Cannabis Smoking* | X | X | X | X |
Marijuana Craving Questionnaire | X | X | X | X |
Cannabis Use Disorder Identification Test | X | X | X | X |
Cannabis Withdrawal Scale | X | X | X | X |
Other | ||||
Barratt Impulsivity Scale-11 | X | X | X | X |
Beck Depression Inventory | X | X | X | X |
Beck Anxiety Inventory | X | X | X | X |
Measures will be administered for both cigarettes and cannabis.
Cotinine to be completed with participants reporting smoking cessation only.